These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

45 related articles for article (PubMed ID: 2013402)

  • 1. P450/losec.
    Moldéus P; Berlin RG; Lu A; Castagnoli N; Carlsson E; Andersson T
    Gastroenterology; 1991 May; 100(5 Pt 1):1488-9. PubMed ID: 2013402
    [No Abstract]   [Full Text] [Related]  

  • 2. Four-week treatment with omeprazole increases the metabolism of caffeine.
    Nousbaum JB; Berthou F; Carlhant D; Riche C; Robaszkiewicz M; Gouerou H
    Am J Gastroenterol; 1994 Mar; 89(3):371-5. PubMed ID: 8122647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose dependent induction of CYP1A2 activity by omeprazole (Antra).
    Rost KL; Brösicke H; Scheffler M; Roots I
    Int J Clin Pharmacol Ther Toxicol; 1992 Nov; 30(11):542-3. PubMed ID: 1490825
    [No Abstract]   [Full Text] [Related]  

  • 4. Omeprazole does not enhance the metabolism of phenacetin, a marker of CYP1A2 activity, in healthy volunteers.
    Xiaodong S; Gatti G; Bartoli A; Cipolla G; Crema F; Perucca E
    Ther Drug Monit; 1994 Jun; 16(3):248-50. PubMed ID: 8085279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P450IA2 and omeprazole.
    Farrell G
    Gastroenterology; 1992 May; 102(5):1822-3. PubMed ID: 1345326
    [No Abstract]   [Full Text] [Related]  

  • 6. Omeprazole induction of cytochrome P-450IA2: the importance of selecting the appropriate human model.
    Watkins PB
    Hepatology; 1993 Apr; 17(4):748-50. PubMed ID: 8477980
    [No Abstract]   [Full Text] [Related]  

  • 7. [Omeprazole and cytochrome P450].
    Petersen KU
    Z Gastroenterol; 1993; 31(7-8):468. PubMed ID: 8379237
    [No Abstract]   [Full Text] [Related]  

  • 8. Antidepressant drug interactions and the cytochrome P450 system: a critical appraisal.
    Riesenman C
    Pharmacotherapy; 1995; 15(6 Pt 2):84S-99S. PubMed ID: 8587855
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific and dose-dependent enzyme induction by omeprazole in human beings.
    Rost KL; Brösicke H; Heinemeyer G; Roots I
    Hepatology; 1994 Nov; 20(5):1204-12. PubMed ID: 7927253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasting-Induced Changes in Hepatic P450 Mediated Drug Metabolism Are Largely Independent of the Constitutive Androstane Receptor CAR.
    de Vries EM; Lammers LA; Achterbergh R; Klümpen HJ; Mathot RA; Boelen A; Romijn JA
    PLoS One; 2016; 11(7):e0159552. PubMed ID: 27434302
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetaminophen produces cataract in DBA2 mice by Ah receptor-independent induction of CYP1A2.
    Qian W; Shichi H
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):337-44. PubMed ID: 10977129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of acetaminophen and trichloroethylene on liver cytochrome P450-dependent monooxygenase system.
    Plewka A; Zielińska-Psuja B; Kowalówka-Zawieja J; Nowaczyk-Dura G; Plewka D; Wiaderkiewicz A; Kamiński M; Orłowski J
    Acta Biochim Pol; 2000; 47(4):1129-36. PubMed ID: 11996102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Omeprazole and lansoprazole are mixed inducers of CYP1A and CYP3A in human hepatocytes in primary culture.
    Curi-Pedrosa R; Daujat M; Pichard L; Ourlin JC; Clair P; Gervot L; Lesca P; Domergue J; Joyeux H; Fourtanier G
    J Pharmacol Exp Ther; 1994 Apr; 269(1):384-92. PubMed ID: 8169844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin.
    Sarich T; Kalhorn T; Magee S; al-Sayegh F; Adams S; Slattery J; Goldstein J; Nelson S; Wright J
    Clin Pharmacol Ther; 1997 Jul; 62(1):21-8. PubMed ID: 9246016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of omeprazole and lansoprazole as inhibitors of cytochrome P450 isoforms.
    Ko JW; Sukhova N; Thacker D; Chen P; Flockhart DA
    Drug Metab Dispos; 1997 Jul; 25(7):853-62. PubMed ID: 9224780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of the "Inje cocktail" for high-throughput evaluation of five human cytochrome P450 isoforms in vivo.
    Ryu JY; Song IS; Sunwoo YE; Shon JH; Liu KH; Cha IJ; Shin JG
    Clin Pharmacol Ther; 2007 Nov; 82(5):531-40. PubMed ID: 17392720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Omeprazole and the cytochrome P450 system of the liver].
    Petersen KU
    Leber Magen Darm; 1993 Sep; 23(5):186-92. PubMed ID: 8412467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined phenotypic assessment of CYP1A2, CYP2C19, CYP2D6, CYP3A, N-acetyltransferase-2, and xanthine oxidase with the "Cooperstown cocktail".
    Streetman DS; Bleakley JF; Kim JS; Nafziger AN; Leeder JS; Gaedigk A; Gotschall R; Kearns GL; Bertino JS
    Clin Pharmacol Ther; 2000 Oct; 68(4):375-83. PubMed ID: 11061577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human cytochrome P450 isoforms. Their genetic heterogeneity and induction by omeprazole.
    Farrell GC; Murray M
    Gastroenterology; 1990 Sep; 99(3):885-9. PubMed ID: 2199294
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined phenotypic assessment of cytochrome p450 1A2, 2C9, 2C19, 2D6, and 3A, N-acetyltransferase-2, and xanthine oxidase activities with the "Cooperstown 5+1 cocktail".
    Chainuvati S; Nafziger AN; Leeder JS; Gaedigk A; Kearns GL; Sellers E; Zhang Y; Kashuba AD; Rowland E; Bertino JS
    Clin Pharmacol Ther; 2003 Nov; 74(5):437-47. PubMed ID: 14586384
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.